Pular para o conteúdo
Merck

Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Stem cell research (2016-11-24)
Anne M Bara, Angelica Messana, Amanda Herring, Dane Z Hazelbaker, Kevin Eggan, Lindy E Barrett
RESUMO

Here, we generated a monoallelic mutation in the TLE3 (Transducin Like Enhancer of Split 3) gene using CRISPR-Cas9 editing in the human embryonic stem cell (hESC) line WA01. The heterozygous knockout cell line, TLE3-447-D08-A01, displays partial loss of TLE3 protein expression while maintaining pluripotency, differentiation potential and genomic integrity.

MATERIAIS
Número do produto
Marca
Descrição do produto

Roche
cOmplete, Minicoquetel inibidor de proteases, Tablets provided in a glass vial
Sigma-Aldrich
Anti-actina monoclonal, α-músculo liso, clone 1A4, ascites fluid
Sigma-Aldrich
Puromicina, ≥98% (HPLC), powder
Sigma-Aldrich
Monoclonal Anti-α-Fetoprotein (AFP) antibody produced in mouse, ascites fluid, clone C3